nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—peripheral nervous system neoplasm	0.481	1	CbGaD
Fesoterodine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0525	0.16	CbGbCtD
Fesoterodine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0525	0.16	CbGbCtD
Fesoterodine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0364	0.111	CbGbCtD
Fesoterodine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0314	0.0961	CbGbCtD
Fesoterodine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0292	0.0894	CbGbCtD
Fesoterodine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0224	0.0685	CbGbCtD
Fesoterodine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0209	0.0639	CbGbCtD
Fesoterodine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0205	0.0627	CbGbCtD
Fesoterodine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.014	0.0428	CbGbCtD
Fesoterodine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0134	0.041	CbGbCtD
Fesoterodine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0132	0.0403	CbGbCtD
Fesoterodine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0123	0.0376	CbGbCtD
Fesoterodine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00838	0.0256	CbGbCtD
Fesoterodine—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000429	0.00223	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000428	0.00223	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000428	0.00223	CcSEcCtD
Fesoterodine—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000428	0.00223	CcSEcCtD
Fesoterodine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000425	0.00221	CcSEcCtD
Fesoterodine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000424	0.00221	CcSEcCtD
Fesoterodine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000421	0.00219	CcSEcCtD
Fesoterodine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000419	0.00218	CcSEcCtD
Fesoterodine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000417	0.00217	CcSEcCtD
Fesoterodine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000416	0.00217	CcSEcCtD
Fesoterodine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000416	0.00217	CcSEcCtD
Fesoterodine—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.00217	CcSEcCtD
Fesoterodine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.00216	CcSEcCtD
Fesoterodine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000414	0.00216	CcSEcCtD
Fesoterodine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000414	0.00216	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000411	0.00214	CcSEcCtD
Fesoterodine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000411	0.00214	CcSEcCtD
Fesoterodine—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000408	0.00213	CcSEcCtD
Fesoterodine—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000408	0.00212	CcSEcCtD
Fesoterodine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000405	0.00211	CcSEcCtD
Fesoterodine—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000405	0.00211	CcSEcCtD
Fesoterodine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.0004	0.00208	CcSEcCtD
Fesoterodine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000394	0.00205	CcSEcCtD
Fesoterodine—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000393	0.00205	CcSEcCtD
Fesoterodine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000391	0.00203	CcSEcCtD
Fesoterodine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000389	0.00203	CcSEcCtD
Fesoterodine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000389	0.00203	CcSEcCtD
Fesoterodine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000387	0.00202	CcSEcCtD
Fesoterodine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000386	0.00201	CcSEcCtD
Fesoterodine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.00201	CcSEcCtD
Fesoterodine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000386	0.00201	CcSEcCtD
Fesoterodine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000381	0.00198	CcSEcCtD
Fesoterodine—Infection—Vincristine—peripheral nervous system neoplasm	0.00038	0.00198	CcSEcCtD
Fesoterodine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000379	0.00197	CcSEcCtD
Fesoterodine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000376	0.00196	CcSEcCtD
Fesoterodine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000376	0.00196	CcSEcCtD
Fesoterodine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000375	0.00195	CcSEcCtD
Fesoterodine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000374	0.00194	CcSEcCtD
Fesoterodine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000372	0.00194	CcSEcCtD
Fesoterodine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000371	0.00193	CcSEcCtD
Fesoterodine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000371	0.00193	CcSEcCtD
Fesoterodine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000371	0.00193	CcSEcCtD
Fesoterodine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000369	0.00192	CcSEcCtD
Fesoterodine—Back pain—Etoposide—peripheral nervous system neoplasm	0.000367	0.00191	CcSEcCtD
Fesoterodine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000366	0.0019	CcSEcCtD
Fesoterodine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000361	0.00188	CcSEcCtD
Fesoterodine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.00187	CcSEcCtD
Fesoterodine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000358	0.00187	CcSEcCtD
Fesoterodine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000358	0.00187	CcSEcCtD
Fesoterodine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000354	0.00184	CcSEcCtD
Fesoterodine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000353	0.00184	CcSEcCtD
Fesoterodine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000353	0.00184	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00035	0.00182	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00035	0.00182	CcSEcCtD
Fesoterodine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.00182	CcSEcCtD
Fesoterodine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000349	0.00182	CcSEcCtD
Fesoterodine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000346	0.0018	CcSEcCtD
Fesoterodine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000346	0.0018	CcSEcCtD
Fesoterodine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000346	0.0018	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000343	0.00178	CcSEcCtD
Fesoterodine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00178	CcSEcCtD
Fesoterodine—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000341	0.00178	CcSEcCtD
Fesoterodine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000341	0.00178	CcSEcCtD
Fesoterodine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000339	0.00177	CcSEcCtD
Fesoterodine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000338	0.00176	CcSEcCtD
Fesoterodine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000336	0.00175	CcSEcCtD
Fesoterodine—Rash—Topotecan—peripheral nervous system neoplasm	0.000333	0.00173	CcSEcCtD
Fesoterodine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000333	0.00173	CcSEcCtD
Fesoterodine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000332	0.00173	CcSEcCtD
Fesoterodine—Cough—Etoposide—peripheral nervous system neoplasm	0.000331	0.00172	CcSEcCtD
Fesoterodine—Headache—Topotecan—peripheral nervous system neoplasm	0.000331	0.00172	CcSEcCtD
Fesoterodine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00033	0.00172	CcSEcCtD
Fesoterodine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00033	0.00172	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00033	0.00172	CcSEcCtD
Fesoterodine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00033	0.00172	CcSEcCtD
Fesoterodine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00033	0.00172	CcSEcCtD
Fesoterodine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00033	0.00172	CcSEcCtD
Fesoterodine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00033	0.00172	CcSEcCtD
Fesoterodine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000329	0.00171	CcSEcCtD
Fesoterodine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000328	0.00171	CcSEcCtD
Fesoterodine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000328	0.00171	CcSEcCtD
Fesoterodine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.0017	CcSEcCtD
Fesoterodine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000327	0.0017	CcSEcCtD
Fesoterodine—Rash—Melphalan—peripheral nervous system neoplasm	0.000326	0.0017	CcSEcCtD
Fesoterodine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000326	0.0017	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.00169	CcSEcCtD
Fesoterodine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00169	CcSEcCtD
Fesoterodine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000323	0.00168	CcSEcCtD
Fesoterodine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00168	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000321	0.00167	CcSEcCtD
Fesoterodine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.00164	CcSEcCtD
Fesoterodine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000315	0.00164	CcSEcCtD
Fesoterodine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.00164	CcSEcCtD
Fesoterodine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000314	0.00163	CcSEcCtD
Fesoterodine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000314	0.00163	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000313	0.00163	CcSEcCtD
Fesoterodine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000312	0.00163	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000312	0.00162	CcSEcCtD
Fesoterodine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000311	0.00162	CcSEcCtD
Fesoterodine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000311	0.00162	CcSEcCtD
Fesoterodine—Infection—Etoposide—peripheral nervous system neoplasm	0.000308	0.0016	CcSEcCtD
Fesoterodine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000307	0.0016	CcSEcCtD
Fesoterodine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000307	0.0016	CcSEcCtD
Fesoterodine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000302	0.00157	CcSEcCtD
Fesoterodine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000302	0.00157	CcSEcCtD
Fesoterodine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000301	0.00157	CcSEcCtD
Fesoterodine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.00156	CcSEcCtD
Fesoterodine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.00155	CcSEcCtD
Fesoterodine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000298	0.00155	CcSEcCtD
Fesoterodine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000293	0.00153	CcSEcCtD
Fesoterodine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00152	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000292	0.00152	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.0015	CcSEcCtD
Fesoterodine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000286	0.00149	CcSEcCtD
Fesoterodine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.00148	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000284	0.00148	CcSEcCtD
Fesoterodine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000282	0.00147	CcSEcCtD
Fesoterodine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.00146	CcSEcCtD
Fesoterodine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000279	0.00145	CcSEcCtD
Fesoterodine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000275	0.00143	CcSEcCtD
Fesoterodine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.00143	CcSEcCtD
Fesoterodine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000274	0.00143	CcSEcCtD
Fesoterodine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00142	CcSEcCtD
Fesoterodine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00142	CcSEcCtD
Fesoterodine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.00141	CcSEcCtD
Fesoterodine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00027	0.00141	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000267	0.00139	CcSEcCtD
Fesoterodine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000267	0.00139	CcSEcCtD
Fesoterodine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000265	0.00138	CcSEcCtD
Fesoterodine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000265	0.00138	CcSEcCtD
Fesoterodine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.00138	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.00137	CcSEcCtD
Fesoterodine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.00137	CcSEcCtD
Fesoterodine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000262	0.00136	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000258	0.00134	CcSEcCtD
Fesoterodine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000255	0.00133	CcSEcCtD
Fesoterodine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000254	0.00132	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000253	0.00132	CcSEcCtD
Fesoterodine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000253	0.00132	CcSEcCtD
Fesoterodine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.00131	CcSEcCtD
Fesoterodine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.00131	CcSEcCtD
Fesoterodine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.0013	CcSEcCtD
Fesoterodine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.0013	CcSEcCtD
Fesoterodine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000249	0.0013	CcSEcCtD
Fesoterodine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.00129	CcSEcCtD
Fesoterodine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000246	0.00128	CcSEcCtD
Fesoterodine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000245	0.00128	CcSEcCtD
Fesoterodine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.00128	CcSEcCtD
Fesoterodine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000243	0.00126	CcSEcCtD
Fesoterodine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00126	CcSEcCtD
Fesoterodine—Rash—Vincristine—peripheral nervous system neoplasm	0.000241	0.00126	CcSEcCtD
Fesoterodine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000241	0.00125	CcSEcCtD
Fesoterodine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00125	CcSEcCtD
Fesoterodine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00125	CcSEcCtD
Fesoterodine—Headache—Vincristine—peripheral nervous system neoplasm	0.00024	0.00125	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.00124	CcSEcCtD
Fesoterodine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.00123	CcSEcCtD
Fesoterodine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000231	0.0012	CcSEcCtD
Fesoterodine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000228	0.00119	CcSEcCtD
Fesoterodine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000228	0.00119	CcSEcCtD
Fesoterodine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000227	0.00118	CcSEcCtD
Fesoterodine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00118	CcSEcCtD
Fesoterodine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00116	CcSEcCtD
Fesoterodine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00116	CcSEcCtD
Fesoterodine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000222	0.00116	CcSEcCtD
Fesoterodine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.00115	CcSEcCtD
Fesoterodine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00022	0.00115	CcSEcCtD
Fesoterodine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000219	0.00114	CcSEcCtD
Fesoterodine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000214	0.00112	CcSEcCtD
Fesoterodine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000213	0.00111	CcSEcCtD
Fesoterodine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000213	0.00111	CcSEcCtD
Fesoterodine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000212	0.0011	CcSEcCtD
Fesoterodine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.0011	CcSEcCtD
Fesoterodine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00109	CcSEcCtD
Fesoterodine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00021	0.00109	CcSEcCtD
Fesoterodine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000208	0.00109	CcSEcCtD
Fesoterodine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000206	0.00107	CcSEcCtD
Fesoterodine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000205	0.00107	CcSEcCtD
Fesoterodine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.00106	CcSEcCtD
Fesoterodine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00105	CcSEcCtD
Fesoterodine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00104	CcSEcCtD
Fesoterodine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.00103	CcSEcCtD
Fesoterodine—Rash—Etoposide—peripheral nervous system neoplasm	0.000195	0.00102	CcSEcCtD
Fesoterodine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000195	0.00102	CcSEcCtD
Fesoterodine—Headache—Etoposide—peripheral nervous system neoplasm	0.000194	0.00101	CcSEcCtD
Fesoterodine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00101	CcSEcCtD
Fesoterodine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.001	CcSEcCtD
Fesoterodine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000995	CcSEcCtD
Fesoterodine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000992	CcSEcCtD
Fesoterodine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000979	CcSEcCtD
Fesoterodine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000967	CcSEcCtD
Fesoterodine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000966	CcSEcCtD
Fesoterodine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000184	0.000958	CcSEcCtD
Fesoterodine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000943	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000937	CcSEcCtD
Fesoterodine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000923	CcSEcCtD
Fesoterodine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000921	CcSEcCtD
Fesoterodine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000912	CcSEcCtD
Fesoterodine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000906	CcSEcCtD
Fesoterodine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000898	CcSEcCtD
Fesoterodine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000895	CcSEcCtD
Fesoterodine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000887	CcSEcCtD
Fesoterodine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000883	CcSEcCtD
Fesoterodine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000878	CcSEcCtD
Fesoterodine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000873	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000867	CcSEcCtD
Fesoterodine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000854	CcSEcCtD
Fesoterodine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000844	CcSEcCtD
Fesoterodine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000831	CcSEcCtD
Fesoterodine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000821	CcSEcCtD
Fesoterodine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000818	CcSEcCtD
Fesoterodine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000817	CcSEcCtD
Fesoterodine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000813	CcSEcCtD
Fesoterodine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000804	CcSEcCtD
Fesoterodine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000796	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000781	CcSEcCtD
Fesoterodine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00078	CcSEcCtD
Fesoterodine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000773	CcSEcCtD
Fesoterodine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000757	CcSEcCtD
Fesoterodine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000745	CcSEcCtD
Fesoterodine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000744	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000739	CcSEcCtD
Fesoterodine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000737	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000722	CcSEcCtD
Fesoterodine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000721	CcSEcCtD
Fesoterodine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000718	CcSEcCtD
Fesoterodine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000716	CcSEcCtD
Fesoterodine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000715	CcSEcCtD
Fesoterodine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000689	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000684	CcSEcCtD
Fesoterodine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000666	CcSEcCtD
Fesoterodine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000665	CcSEcCtD
Fesoterodine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000661	CcSEcCtD
Fesoterodine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000649	CcSEcCtD
Fesoterodine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00064	CcSEcCtD
Fesoterodine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000619	CcSEcCtD
Fesoterodine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000616	CcSEcCtD
Fesoterodine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.0006	CcSEcCtD
Fesoterodine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000598	CcSEcCtD
Fesoterodine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000592	CcSEcCtD
Fesoterodine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000572	CcSEcCtD
Fesoterodine—Rash—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00057	CcSEcCtD
Fesoterodine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00057	CcSEcCtD
Fesoterodine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000567	CcSEcCtD
Fesoterodine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000553	CcSEcCtD
Fesoterodine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000537	CcSEcCtD
Fesoterodine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000528	CcSEcCtD
Fesoterodine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000527	CcSEcCtD
Fesoterodine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000524	CcSEcCtD
Fesoterodine—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.55e-05	0.000497	CcSEcCtD
